1-(TETRAHYDRO-2H-PYRAN-4-YL)CYCLOPROPANAMINE HCL, 95.0%, 1g

5-Bromo-1,7-naphthyridin-8-ol, 95.0%, 100mg

1-Chloro-2,4-dimethoxybenzene, 95.0%, 1g

2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzamide, 95.0%, 1g

3,5-dimethyl-2-(1H-pyrazol-1-yl)benzaldehyde, 95.0%, 1g

2-tert-Butyloxycarbonylaminomethyl-5-p-Tolyl-[1,3,4]oxadiazole, 95.0%, 5g

1,6-DIBROMONAPHTHALENE, 95.0%, 10g

3-Bromo-5-fluoro-benzenesulfonamide, 95.0%, 1g

1-(4-Chlorophenyl)piperidine-4-carboxylic acid, 98%, 1g

HPLC column NUCLEODUR® C8 Gravity 5 µm, 250 mm, 4 mm, 1 Piece(s)

Ethyl 6-Methyl-2-oxo-3-cyclohexene-1-carboxylate (mixture of isomers)>95.0%(GC)5g

(1R,2R)-2-Fluorocyclohexanamine hydrochloride, 95%, 250mg

1,4-Diiodo-2-nitrobenzene, 97%, 10g